Cesca Therapeutics 7.53M share offering priced at $1.50 Cesca Therapeutics announced the pricing of an underwritten public offering of 7.53M units, consisting of an aggregate of 7.53M shares and warrants to purchase 2.259M shares of the, at a price of $1.50 per unit. The warrants will be exercisable immediately upon issuance at an exercise price of $1.55 per share and will expire five years from the date of issuance. All of the units in the offering are being sold by Cesca. The gross proceeds to Cesca from the offering are expected to be approximately $11.3M. The offering is expected to close on or about June 18. Maxim Group is acting as sole book-running manager and H.C. Wainwright & Co. is acting as a co-manager for the offering.
Cesca Therapeutics compliant with Nasdaq listing requirements Cesca Therapeutics received a letter from Nasdaq Listings Qualifications indicating that the company complies with Nasdaq listing rules because the company has filed its Forms 10-Q for the periods ended December 31, 2014 and March 31, 2015 with the SEC.